Screening and Treating Hepatitis C at the Penn Center for Viral Hepatitis

– Infection with hepatitis C is a major public health problem
here in the United States and throughout the world. I’m Dr. Vincent Lo Re from Penn Medicine, and I’m an infectious disease physician and researcher focusing on chronic hepatitis C virus infection. Today I’m going to explain who’s at risk for hepatitis C, how it affects the body, and what treatments are
available for this disease. Hepatitis C is transmitted
primarily through exposure to blood or
body fluids, as a result; today, 4 million Americans
are chronically infected with hepatitis C and
another 170 million people are infected worldwide. People who may have an
especially increased risk for chronic
hepatitis C and who should be screened for infection
include those who have used injection or intranasal
drugs, received a blood or cloning factor
transfusion prior to 1992, have undergone hemodialysis,
or are children of hepatitis C infected mothers. In addition, recent data
from the CDC indicate that people born between 1945
and 1965 have a much greater risk of contracting hepatitis
C, so any baby boomers should be sure to get screened. If left untreated, chronic
hepatitis C can lead to cirrhosis, liver cancer,
and liver failure. Fortunately, direct
acting oral treatments for chronic hepatitis C are now available; these therapies typically
require only eight to twelve weeks of once daily
pills, have few side effects, and result in greater
than 94% chance of curing chronic hepatitis C. Here at Penn Medicine, we
have a multi disciplinary team of clinicians, nurses,
pharmacists, dieticians, and behavioral counselors;
all specializing in hepatitis C and HIV,
hepatitis C coinfection. We perform a comprehensive
evaluation focusing on hepatitis C and liver health. Our practitioners provide
detailed education about all aspects of
hepatitis C virus infection; including a proper diet to
avoid liver complications. We have a FibroScan imaging
machine that noninvasively measures liver scarring; so
we can accurately evaluate and treat any liver damage. Our pharmacists will review
medications to ensure there are no issues with
the treatments we prescribe. We have extensive
experience working will all types of insurance to obtain approvals for treatment and we are dedicated to working closely with our patients to cure their chronic hepatitis C infection. If you think you or someone you know is at risk for hepatitis
C; or if you’re interested in more information about
our program, visit our website or call 800-789-PENN. We will connect you to one
of our outstanding providers and start you on the road to a cure of your chronic hepatitis C infection.

3 comments

  1. My professor is an RN and she tells me it can only be contracted from blood to blood contact. I didn't know bodily fluids was an entry port for the virus…

  2. Estoy muy preocupada tengo hepatitis c seguro social dice que estoy en tercera etapa no sé qué significa y que en México no hay tratamiento para la tercera etapa y no se asta que grado o si lo sé peligroso en la etapa en que estoy nadie me explica nada.

Leave a Reply

(*) Required, Your email will not be published